ask="1.880"
ask_size="200"
average_daily_volume="162039"
bid="0.950"
bid_size="200"
book_value="0.333"
change="-0.015"
change_from_200_day_moving_average="-0.519"
change_from_50_day_moving_average="-0.084"
change_from_52_week_high="-2.275"
change_From_52_week_low="0.405"
change_in_percent="-1.230%"
close="1.205"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.810"
ebitda="-19.61M"
eps_estimate_current_year="-0.720"
eps_estimate_next_quarter="-0.150"
eps_estimate_next_year="-0.620"
ex_dividend_date="N/A"
float_shares="25247000"
high="1.258"
high_52_weeks="3.480"
last_trade_date="2/21/2017"
last_trade_price="1.205"
last_trade_size="220"
last_trade_time="3:58pm"
low="1.200"
low_52_weeks="0.800"
market_capitalization="30.64M"
moving_average_200_day="1.724"
moving_average_50_day="1.289"
name="Repros Therapeutics Inc."
notes="N/A"
one_year_target_price="5.250"
open="1.250"
pe_ratio="N/A"
peg_ratio="-0.060"
percent_change_from_200_day_moving_average="-30.094%"
percent_change_from_50_day_moving_average="-6.483%"
percent_change_from_52_week_high="-65.374%"
percent_change_from_52_week_low="+50.625%"
previous_close="1.220"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.664"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="25425000"
short_ratio="4.860"
stock_exchange="NCM"
symbol="RPRX"
volume="88315"
weeks_range_52="0.800 - 3.480"
